BIOPSY OF THE LYMPH NODES IN BREAST CANCER
Authors: E.M. Bit-Sava, M.G. Anchabandze, M.A. Monogarova, V.M. Moiseyenko
DOI: https://www.doi.org/10.31917/1902138
The status of the lymph nodes largely determines the treatment strategy and allow to evaluate the prognosis. In patients
with breast cancer with clinically negative axillary lymph nodes, a biopsy of the signaling lymph nodes (BSLN) should be
used. In elderly patients with breast, cancer with positive axillary lymph nodes carrying out BSLN compared with axillary
lymph node dissection does not impair the long-term survival rates. One of the features of neoadjuvant chemotherapy is
to reduce breast cancer that provides volume reduction surgery, as in breast and in the axillary region. The possibility of
extension of indications of BSLU for patients with cN+ which turned into category cN- after a neoadjuvant chemotherapy
is studied